443 related articles for article (PubMed ID: 17240435)
21. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.
Gu C; Zhang Z; Yu Y; Liu Y; Zhao F; Yin L; Feng Y; Chen X
Cancer Sci; 2011 Mar; 102(3):557-64. PubMed ID: 21205080
[TBL] [Abstract][Full Text] [Related]
22. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Cui X; Schiff R; Arpino G; Osborne CK; Lee AV
J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis.
Kim SH; Lee HW; Kim YH; Koo YH; Chae HD; Kim CH; Lee PR; Kang BM
Hum Reprod; 2009 May; 24(5):1133-41. PubMed ID: 19168872
[TBL] [Abstract][Full Text] [Related]
24. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
26. ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer.
Tu BB; Lin SL; Yan LY; Wang ZY; Sun QY; Qiao J
Am J Obstet Gynecol; 2011 Sep; 205(3):227.e1-6. PubMed ID: 21684519
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma.
Kim YB; Berek JS; Martinez-Maza O; Satyaswaroop PG
Gynecol Oncol; 1996 Apr; 61(1):97-100. PubMed ID: 8626126
[TBL] [Abstract][Full Text] [Related]
28. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
[TBL] [Abstract][Full Text] [Related]
29. Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.
Zhang H; Yan L; Bai Y; Li C; Guo Q; Wang C; Zhao X; Li M
Gynecol Oncol; 2015 Mar; 136(3):549-53. PubMed ID: 25451692
[TBL] [Abstract][Full Text] [Related]
30. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
[TBL] [Abstract][Full Text] [Related]
31. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
32. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
33. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
34. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
36. [Endocrinological contribution for invasion and metastasis in gynecological cancers].
Fujimoto J
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831
[TBL] [Abstract][Full Text] [Related]
37. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
38. Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.
Zhao S; Li G; Yang L; Li L; Li H
Oncol Lett; 2013 Jan; 5(1):139-144. PubMed ID: 23255909
[TBL] [Abstract][Full Text] [Related]
39. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
40. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch.
Bhatti SF; Rao NA; Okkens AC; Mol JA; Duchateau L; Ducatelle R; van den Ingh TS; Tshamala M; Van Ham LM; Coryn M; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2007 Oct; 33(3):294-312. PubMed ID: 16956744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
